SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-244019
Filing Date
2019-09-12
Accepted
2019-09-12 17:19:03
Documents
4
Period of Report
2019-09-10
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d798377d8k.htm 8-K 29750
2 EX-10.1 d798377dex101.htm EX-10.1 20067
3 EX-10.2 d798377dex102.htm EX-10.2 19521
4 EX-10.3 d798377dex103.htm EX-10.3 20186
  Complete submission text file 0001193125-19-244019.txt   90889
Mailing Address 3 CENTER PLAZA SUITE 610 BOSTON MA 02108
Business Address 3 CENTER PLAZA SUITE 610 BOSTON MA 02108 617-622-4003
ZAFGEN, INC. (Filer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36510 | Film No.: 191091008
SIC: 2834 Pharmaceutical Preparations